Neurosurgical Care, LLC, Royersford, Pennsylvania, USA.
World Neurosurg. 2013 Feb;79(2):369-74.e1-12. doi: 10.1016/j.wneu.2012.03.022. Epub 2012 Apr 3.
No guidelines exist regarding external cervical orthoses (ECO) after atlantoaxial fusion. We reviewed published series describing C1-2 posterior instrumented fusions with screw-rod constructs (SRC) or transarticular screws (TAS) and compared rates of fusion with and without postoperative ECO.
Online databases were searched for English-language articles between 1986 and April 2011 describing ECO use after posterior atlantoaxial instrumentation with SRC or TAS. Eighteen studies describing 947 patients who had SRC (± ECO: 254 of 693 patients), and 33 studies describing 1424 patients with TAS (± ECO: 525 of 899 patients) met inclusion criteria. Meta-analysis techniques were applied to estimate rates of fusion with and without ECO use.
All studies provided class III evidence, and no studies directly compared outcomes with or without ECO use. There was no significant difference in the proportion of patients who achieved successful fusion between patients treated with ECO and without ECO for SRC or TAS patients. Point estimates and 95% confidence intervals (CI) for rates of fusion ± ECO were 97.4% (CI: 95.2% to 98.6%) versus 97.9% (CI: 93.6% to 99.3%) for SRC and 93.6% (CI: 90.7% to 95.6%) versus 95.3% (CI: 90.8% to 97.7%) for TAS. There was no correlation between duration of ECO treatment and fusion (dose effect).
After C1-2 fusion with modern instrumentation, ECO may be unnecessary (class III). Some centers recommend ECO use with patients with softer bone quality (class IV). Prospective, randomized studies with validated radiographic and clinical outcome metrics are necessary to determine the utility of ECO after C1-2 fusion and its impact on patient comfort and cost.
寰枢椎融合术后使用外部颈椎矫形器(ECO)尚无指南。我们回顾了描述使用螺钉棒结构(SRC)或经关节螺钉(TAS)进行 C1-2 后路器械融合的已发表系列,并比较了有和无术后 ECO 的融合率。
在线数据库检索了 1986 年至 2011 年 4 月期间发表的描述使用 SRC 或 TAS 进行后路寰枢椎器械固定后使用 ECO 的英文文章。有 18 项研究描述了 947 例接受 SRC 的患者(± ECO:693 例患者中有 254 例),33 项研究描述了 1424 例接受 TAS 的患者(± ECO:899 例患者中有 525 例)符合纳入标准。应用荟萃分析技术来估计有和无 ECO 使用的融合率。
所有研究均提供了 III 级证据,没有研究直接比较有无 ECO 使用的结果。使用 ECO 和未使用 ECO 的 SRC 或 TAS 患者的成功融合比例无显著差异。ECO 治疗的点估计值和 95%置信区间(CI)分别为 97.4%(CI:95.2%至 98.6%)与 97.9%(CI:93.6%至 99.3%)用于 SRC,93.6%(CI:90.7%至 95.6%)与 95.3%(CI:90.8%至 97.7%)用于 TAS。ECO 治疗时间与融合之间无相关性(剂量效应)。
在使用现代器械进行 C1-2 融合后,ECO 可能是不必要的(III 级)。一些中心建议在骨质量较软的患者中使用 ECO(IV 级)。需要进行前瞻性、随机研究,使用经过验证的影像学和临床结果指标来确定 C1-2 融合后 ECO 的效用及其对患者舒适度和成本的影响。